Most pundits have AXA as a buy or strong buy recommendation. The SP is still down 30% from 12 months ago. The profit foreacast looks exceptional. Can anyone explain why there seems to be no movement in the SP?
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025